Progyny provides fertility and family-building benefits solutions sold primarily to employers as part of employee health benefits. Its offering covers services such as IVF and related care through a curated provider network and care management model. The company targets large and mid-size employers seeking specialized reproductive-health coverage beyond standard insurance.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 324 | — | 15.1 | — |
| Q2 2025 | 332.9 | — | 17.1 | — |
| Q3 2025 | 313.4 | — | 13.9 | — |
| Q4 2025 | 318.4 | — | 12.5 | — |
| Q1 2026 | 328.5 | 1.4% | 24.2 | 60.9% |
| Q2 2026 | 350.5 | 5.3% | 28.1 | 63.9% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Generate Biomedicines, Inc. (GENB), Preformed Line Products Company (PLPC), Nayax Ltd. (NYAX), Keel Infrastructure Corp. (KEEL), Innodata Inc. (INOD), Melco Resorts & Entertainment Limited (MLCO)